Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz dispersible tablet versus oral solution in children with HIV infection
RBR-5whk7cPhase 2Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Universidade Federal de Minas Gerais. Primary endpoints: Toxicity evaluation and Drug dosing parameter evaluation. Started Jun 2016; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on RBR-5whk7c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5whk7c.